skip to content

Department of Oncology


Charlotte Coles (Dept of Oncology, Breast Cancer Programme and lead for CRUK RadNet Cambridge) has co-authored a new European Consensus Statement to improve breast cancer radiotherapy treatment.

The Consensus from ESTRO-ACROP: European Society of Therapeutic Radiology and Oncology Advisory Committee in Radiation Oncology Practice, published by Lancet Oncology, states that 3-week breast radiotherapy can be offered to any patient for any indication and 1-week breast radiotherapy can be offered for patients who do not need lymph node radiotherapy.

Charlotte said: “In the clinical world Consensus statements can drive change – so this really is the next step to changing standard of care in Europe and the rest of the world.” 

Click here for more information on the European Consensus Statement on breast cancer radiotherapy.